Evidence mapPaperPMID 41645903Full record

ArticleCirculation2026

TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn

Xin Li, Xiaohan Li, Cindy Xintong Li, Jianlin Feng, Zhichao Yue, Jiajie Yan, Masayuki Matsushita, Yibing Qyang, Loren W Runnels, Xun Ai and 1 more

Abstract read
In one paragraph

Article in Circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xin LiPat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.ORCID 0009-0009-1205-1976
Xiaohan LiPat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.
Cindy Xintong LiPat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.ORCID 0009-0006-8836-6737
Jianlin FengPat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.
Zhichao YuePat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.
Jiajie YanDepartment of Physiology and Cell Biology, College of Medicine/Wexner Medical Center, The Ohio State University, Columbus (J.Y., X.A.).
Masayuki MatsushitaDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan (M.M.).
Yibing QyangYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT (Xin Li, Y.Q.).ORCID 0000-0002-0332-2449
Loren W RunnelsDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ (L.W.R.).ORCID 0000-0002-2537-7360
Xun AiDepartment of Physiology and Cell Biology, College of Medicine/Wexner Medical Center, The Ohio State University, Columbus (J.Y., X.A.).ORCID 0000-0003-0739-0286
Lixia YuePat and Jim Calhoun Cardiology Center (Xin Li, Xiaohan Li, C.X.L., J.F., Z.Y., L.Y.), University of Connecticut School of Medicine, Farmington.ORCID 0000-0002-3558-091X

Funding

Atrial and blood JNK in Postoperative AFR01HL168728 · OHIO STATE UNIVERSITY · 2025 to 2025
$685k
Calcium Signaling Mechanisms in Cardiac FibrogenesisR01HL171486 · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · 2025 to 2025
$664k
The JNK2-NLRP3 nexus in atrial fibrillation and its anti-AF therapeutic potentialsR01AA031056 · OHIO STATE UNIVERSITY · 2025 to 2025
$584k
Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic StrokeR01NS131661 · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · 2025 to 2025
$407k
NHLBI NIH HHS R01 HL146744NHLBI NIH HHS R01 HL147350NHLBI NIH HHS R01 HL168728NHLBI NIH HHS R01 HL171486NIAAA NIH HHS R01 AA031056NINDS NIH HHS R01 NS131661
6 · The paper itself

Abstract

backgroundIschemic heart disease is one of the leading causes of death worldwide. Timely reperfusion is necessary for myocardium salvage but triggers paradoxical cardiomyocyte death and contributes to up to 50% of the final infarct size, known as lethal ischemia/reperfusion (I/R) injury. TRPM7 (transient receptor potential melastatin 7) is a divalent cation-permeable, nonselective channel kinase that can sense oxidative stress and release Zn

methodsTRPM7 expression was determined in hearts from patients with ischemic heart failure and I/R-injured mice. Global (

resultsWe found that TRPM7 was significantly upregulated in myocardium from both patients with ischemic heart failure and I/R-injured mice. Global TRPM7 deficiency markedly reduced infarct size and improved cardiac function after I/R injury. Using

conclusionsTRPM7-mediated intracellular Zn

Indexed as

HomeostasisMyocardial Reperfusion InjuryMyocytes, CardiacProtein Serine-Threonine KinasesTRPM Cation ChannelsZincAnimalsFemaleHumansMaleMiceMice, Inbred C57BLMice, KnockoutProtein Serine-Threonine KinasesTRPM7 protein, humanTrpm7 protein, mouseTRPM Cation ChannelsZinccardiomyocytehiPSCischemia-reperfusion injurypyroptosisTRPM7Zn2+ homeostasis

Identifiers

PMID41645903
PMCPMC13019533

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.